The Medicare artificial intelligence pilot program does not currently impose prior authorization requirements on chronic obstructive pulmonary disease medications.

Artificial intelligence research, products, and impact across society.

Health news, debates, and claims covering public health, mental health, nutrition, medical care, and health policy.